Chronic Pain Programs Seed-To-Sale Topical 
CannaTech
JANUARY 16, 2019
Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. It is not a story about profiting off of people.
Cannabis Law Report
FEBRUARY 17, 2020
For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Heather Allman.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MARCH 19, 2020
This advisory provides an overview of key regulatory activity and priorities that should be on the radar of any company engaged in the development or sale of products that contain CBD. Godfrey , Evelina J. Norwinski , Elizabeth Trentacost , Camille Heyboer and Atiq Chowdhury. Arnold & Porter.
SpeedWeed
MAY 6, 2021
46 proposes implementing a medical program that would open the application process for potential patients by Sept. Some of the conditions include: cancer, terminal illness, depression, epilepsy, anxiety or panic disorder, chronic pain, spasticity, autism, Tourette syndrome and post-traumatic stress disorder. . Tim Melson, S.B.
SpeedWeed
MAY 8, 2021
46 proposes implementing a medical program that would open the application process for potential patients by Sept. Some of the conditions include: cancer, terminal illness, depression, epilepsy, anxiety or panic disorder, chronic pain, spasticity, autism, Tourette syndrome and post-traumatic stress disorder. . Tim Melson, S.B.
SpeedWeed
MAY 6, 2021
46 proposes implementing a medical program that would open the application process for potential patients by Sept. Some of the conditions include: cancer, terminal illness, depression, epilepsy, anxiety or panic disorder, chronic pain, spasticity, autism, Tourette syndrome and post-traumatic stress disorder. . Tim Melson, S.B.
Cannabis Law Report
OCTOBER 17, 2019
As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state.
Expert insights. Personalized for you.
89 
Let's personalize your content